Search Results - "Fedor, Dawn M."

DHA supplementation decreases serum C-reactive protein and other markers of inflammation in hypertriglyceridemic men by Kelley, Darshan S, Siegel, David, Fedor, Dawn M, Adkins, Yuriko, Mackey, Bruce E

“…Dietary (n-3) PUFA reduce inflammation, an independent risk factor for cardiovascular disease. The antiinflammatory effects of docosahexaenoic acid (DHA) in…”
Get more information

Vitamin A metabolism and mucosal immune function are distinct between BALB/c and C57BL/6 mice by Goverse, Gera, Olivier, Brenda J., Molenaar, Rosalie, Knippenberg, Marlene, Greuter, Mascha, Konijn, Tanja, Cook, Emma C. L., Beijer, Marieke R., Fedor, Dawn M., den Haan, Joke M. M., Napoli, Joseph L., Bouma, Gerd, Mebius, Reina E.

“…The vitamin A metabolite retinoic acid (RA) has been reported to suppress Th1 responses and enhance Th2 responses. Here, we investigated whether differences in…”
Get full text

DHA concentration of red blood cells is inversely associated with markers of lipid peroxidation in men taking DHA supplement by Shichiri, Mototada, Adkins, Yuriko, Ishida, Noriko, Umeno, Aya, Shigeri, Yasushi, Yoshida, Yasukazu, Fedor, Dawn M., Mackey, Bruce E., Kelley, Darshan S.

“…An increase in the proportion of fatty acids with higher numbers of double bonds is believed to increase lipid peroxidation, which augments the risk for many…”
Get full text

Development of a thermostable nanoemulsion adjuvanted vaccine against tuberculosis using a design-of-experiments approach by Kramer, Ryan M, Archer, Michelle C, Orr, Mark T, Dubois Cauwelaert, Natasha, Beebe, Elyse A, Huang, Po-Wei D, Dowling, Quinton M, Schwartz, Alicia M, Fedor, Dawn M, Vedvick, Thomas S, Fox, Christopher B

“…Adjuvants have the potential to increase the efficacy of protein-based vaccines but need to be maintained within specific temperature and storage conditions…”
Get full text

Examination of Fluconazole-Induced Alopecia in an Animal Model and Human Cohort by Thompson, 3rd, George R, Krois, Charles R, Affolter, Verena K, Everett, Angela D, Varjonen, E Katarina, Sharon, Victoria R, Singapuri, Anil, Dennis, Michael, McHardy, Ian, Yoo, Hong Sik, Fedor, Dawn M, Wiederhold, Nathan P, Aaron, Phylicia A, Gelli, Angie, Napoli, Joseph L, White, Stephen D

“…Fluconazole-induced alopecia is a significant problem for patients receiving long-term therapy. We evaluated the hair cycle changes of fluconazole in a rat…”
Get full text

Dietary Docosahexaenoic Acid and trans-10, cis-12-Conjugated Linoleic Acid Differentially Alter Oxylipin Profiles in Mouse Periuterine Adipose Tissue by Adkins, Yuriko, Belda, Benjamin J., Pedersen, Theresa L., Fedor, Dawn M., Mackey, Bruce E., Newman, John W., Kelley, Darshan S.

“…Diets containing high n-3 polyunsaturated fatty acids (PUFA) decrease inflammation and the incidence of chronic diseases including cardiovascular disease and…”
Get full text

Staining and Transfer Techniques for SDS-PAGE Gels to Minimize Oil-in-Water Emulsion Adjuvant Interference by Schwartz, Alicia M, Chan, Michelle Y, Fedor, Dawn M, Sivananthan, Sandra J, Kramer, Ryan M

“…Adjuvants in modern vaccines boost and shape immune responses and allow for antigen dose-sparing. Analysis of protein antigens in the presence of adjuvants can…”
Get more information

Interactions Between Antigens and Nanoemulsion Adjuvants: Separation and Characterization Techniques by Chan, Michelle Y, Fedor, Dawn M, Phan, Tony, V, Lucien Barnes, Kramer, Ryan M

“…Determining the association of vaccine components in a formulation is of interest for designing and optimizing well characterized vaccines. Three methods are…”
Get more information

Lyophilization of an Adjuvanted Mycobacterium tuberculosis Vaccine in a Single-Chamber Pharmaceutical Cartridge by Barnes V, Lucien, Fedor, Dawn M., Williams, Simon, Dowling, Quinton M., Archer, Michelle C., Cloutier, Sylvain, Parker, Sarah, Vedvick, Thomas S., Fox, Christopher B., Kramer, Ryan M.

“…Although substantial effort has been made in the development of next-generation recombinant vaccine systems, maintenance of a cold chain is still typically…”
Get full text

Dietary docosahexaenoic acid reverses nonalcoholic steatohepatitis and fibrosis caused by conjugated linoleic acid supplementation in mice by Adkins, Yuriko, Fedor, Dawn M., Mackey, Bruce E., Wu, Jian, Kelley, Darshan S.

“…•DHA feeding in mice to study reversal of NAFLD caused by CLA, a trans fatty acid.•DHA decreased liver inflammation and fibrosis in CLA-induced NAFLD.•DHA…”
Get full text

Docosahexaenoic acid prevents trans-10, cis-12-conjugated linoleic acid-induced nonalcoholic fatty liver disease in mice by altering expression of hepatic genes regulating fatty acid synthesis and oxidation by Fedor, Dawn M, Adkins, Yuriko, Mackey, Bruce E, Kelley, Darshan S

“…Concomitant supplementation with docosahexaenoic acid (22:6 n-3; DHA) prevented trans-10, cis-12-conjugated linoleic acid (CLA)-induced nonalcoholic fatty…”
Get more information

The effect of docosahexaenoic acid on t10, c12-conjugated linoleic acid-induced changes in fatty acid composition of mouse liver, adipose, and muscle by Fedor, Dawn M, Adkins, Yuriko, Newman, John W, Mackey, Bruce E, Kelley, Darshan S

“…Concomitant supplementation of 1.5% docosahexaenoic acid (22:6 n-3; DHA) with 0.5% t10, c12-conjugated linoleic acid (18:2 n-6; CLA) prevented the CLA-induced…”
Get more information

Docosahexaenoic acid (DHA) prevents trans‐10, cis‐12 conjugated linoleic acid (CLA)‐induced insulin resistance (IR) and non‐alcoholic fatty liver disease (NAFLD) but not adipose tissue inflammatory markers in mice by Fedor, Dawn M, Adkins, Yuriko, Kelley, Darshan S

“…We previously reported that CLA induced IR and NAFLD in mice, both of which could be prevented by the concomitant supplementation with DHA. The objective of…”
Get full text